Literature DB >> 15261293

Molecular mechanisms of adefovir sensitivity and resistance in HBV polymerase mutants: a molecular dynamics study.

Vikas Yadav1, Chung K Chu.   

Abstract

Molecular modeling studies of adefovir diphosphate with the wild type and the mutant HBV polymerase-DNA complex demonstrated that the increase in adefovir sensitivity toward HBV polymerase mutants (rtL180M, rtM204V/I, rtL180M-M204V/I) is a result of increased van der Waals interaction and is supplemented by the decreased affinity of natural substrate toward the mutant HBV polymerase. In the case of rtN236T mutant, loss of two hydrogen bonds accompanied by significant decrease in electrostatic interactions is observed, which explains the observed decrease in drug sensitivity and binding affinity of adefovir diphosphate toward the rtN236T mutant HBV polymerase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15261293     DOI: 10.1016/j.bmcl.2004.05.075

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  9 in total

1.  Novel acyclic nucleoside phosphonate analogues with potent anti-hepatitis B virus activities.

Authors:  C Ying; A Holy; D Hocková; Z Havlas; E De Clercq; J Neyts
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

2.  Inhibition of hepatitis B virus polymerase by entecavir.

Authors:  David R Langley; Ann W Walsh; Carl J Baldick; Betsy J Eggers; Ronald E Rose; Steven M Levine; A Jayne Kapur; Richard J Colonno; Daniel J Tenney
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

3.  Computational model of hepatitis B virus DNA polymerase: molecular dynamics and docking to understand resistant mutations.

Authors:  Pankaj R Daga; Jinsong Duan; Robert J Doerksen
Journal:  Protein Sci       Date:  2010-04       Impact factor: 6.725

4.  Understanding the molecular basis of HBV drug resistance by molecular modeling.

Authors:  Ashoke Sharon; Chung K Chu
Journal:  Antiviral Res       Date:  2008-08-31       Impact factor: 5.970

5.  Binding sensitivity of adefovir to the polymerase from different genotypes of HBV: molecular modeling, docking and dynamics simulation studies.

Authors:  Jing Li; Yun Du; Xian Liu; Qian-cheng Shen; Ai-long Huang; Ming-yue Zheng; Xiao-min Luo; Hua-liang Jiang
Journal:  Acta Pharmacol Sin       Date:  2012-12-03       Impact factor: 6.150

6.  Antiviral efficacy of adefovir dipivoxil versus lamivudine in patients with chronic hepatitis B sequentially treated with lamivudine and adefovir due to lamivudine resistance.

Authors:  Yeon Seok Seo; Ji Hoon Kim; Jong Eun Yeon; Jong-Jae Park; Jae-Seon Kim; Kwan Soo Byun; Young-Tae Bak; Chang Hong Lee
Journal:  World J Gastroenterol       Date:  2007-08-14       Impact factor: 5.742

Review 7.  Discovery and development of anti-HBV agents and their resistance.

Authors:  Kyun-Hwan Kim; Nam Doo Kim; Baik-Lin Seong
Journal:  Molecules       Date:  2010-08-27       Impact factor: 4.411

8.  Mechanistic characterization and molecular modeling of hepatitis B virus polymerase resistance to entecavir.

Authors:  Ann W Walsh; David R Langley; Richard J Colonno; Daniel J Tenney
Journal:  PLoS One       Date:  2010-02-12       Impact factor: 3.240

9.  Impact of rtI233V mutation in hepatitis B virus polymerase protein and adefovir efficacy: Homology modeling and molecular docking studies.

Authors:  Ashrafali Mohamed Ismail; Om Prakash Sharma; Muthuvel Suresh Kumar; Rajesh Kannangai; Priya Abraham
Journal:  Bioinformation       Date:  2013-02-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.